• Liquid chromatography reveals AGEs as biomarkers for MS


Liquid chromatography reveals AGEs as biomarkers for MS

Nov 02 2010

Analysis conducted using liquid chromatography with tandem mass spectrometry (LC-MS-MS) has indicated that advanced glycation end products (AGEs) can act as biomarkers for the presence of multiple sclerosis (MS) in patients.

Comparison carried out with LC-MS-MS looked at the presence of the AGEs N-(Carboxymethyl)lysine (CML) and N-(Carboxyethyl)lysine (CEL) in MS patients and a healthy control group.

A significantly higher plasma level of CEL was seen in MS patients, although no significant difference was detected in CML levels.

However, the researchers conclude that CEL in particular and AGEs in general may both represent further investigative avenues for the discovery of MS biomarkers.

The team working on the project included representatives of the Jacobs Neurological Institute and the Biopolymer & Proteomics Resources Roswell Park Cancer Institute in Buffalo, along with the Kinkel Neurologic Center in Williamsville.

Findings were published in the Journal of Neuroinflammation, which carries research reports on all elements of the central nervous system's innate immunological responses.

Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions


NGVS 2024

May 23 2024 Beijing, China


May 28 2024 Tel Aviv, Israel


May 28 2024 Leuven, Belgium

PREP 2024

May 28 2024 Philadelphia, PA, USA


May 29 2024 Beijing, China

View all events